ACCP Research

Zacks - August 18, 2010 Research Update

Zacks - July 2010 Research Update

ZACK'S INITIATES COVERAGE ON ACCP WITH OUTPERFORM AND $8 TARGET

Access Pharma: Griffin Securities 7/30/09

Access Pharma: NextWave 12/16/09

Access Pharma: January 2010 Presentation

MuGard Product Sheet

christine.berni@accesspharma.com

www.AccessPharma.com

2600 Stemmons Freeway

Suite 176

Dallas, TX 75207

P: 214.905.5100

F: 214.905.5101

Research Report| Presentation Downloads:

Access Pharma: Griffin Securities 7/30/09

Access Pharma: NextWave 12/16/09

Access Pharma: January 2010 Presentation

Contact Us

First Name

Last Name

Email (we will keep your email completely private)

Message

Access Pharma Blog

Current Articles | RSS Feed

Access Pharma (OTCBB: ACCP) - ACCP Tech Trade Video

Posted by Mike Sweeney on Sat, Aug 21, 2010 @ 07:56

Email This

Add to delicious

delicious

ACCP Tech Trade - August 21, 2010

Tags: ACCESS PHARMACEUTICALS, ACCP, ACCP.OB, thiarabine, investor, technical trade, call, zacks, mugard, oncology, outperform

Comments

Currently, there are no comments. Be the first to post one!

Post Comment
Name *
Email *
Website (optional)
Comment * Allowed tags: <a> link, <b> bold, <i> italics
Receive email when someone replies. Subscribe to this blog by email.

ACCP Landing Page

accp proactive

ACCP @ Yahoo! Finance News

MuGard Advocate Interviewed on ABC Tampa News at Noon

Wed, 07 Dec 2011 13:30:00 GMT

ACCESS PHARMACEUTICALS INC Financials

Fri, 18 Nov 2011 18:04:24 GMT

On The Fly: Analysts Initiation Summary

Wed, 16 Nov 2011 13:37:02 GMT

On The Fly: Analysts Initiation Summary

Tue, 15 Nov 2011 13:41:01 GMT

Access Pharmaceuticals Provides Third Quarter Update on MuGard Commercial Activities

Tue, 15 Nov 2011 13:30:00 GMT

Access Pharmaceuticals initiated with an Outperform at Cowen

Monday, Nov 14, 2011

ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report

Mon, 14 Nov 2011 22:02:36 GMT

ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report

Mon, 14 Nov 2011 22:02:36 GMT

Twitter @accesspharma

Accesspharma: MuGard's ready-to-use viscous liquid is tasteless, and is safe to swallow. See http://t.co/HjHash6p #cancer

Fri, 03 Feb 2012 20:55:25 +0000

Accesspharma: There are an estimated 400,000 officially diagnosed cases of oral mucositis in the US every year! #MuGard http://t.co/HjHash6p

Fri, 03 Feb 2012 20:34:26 +0000

Accesspharma: Breast cancer regimens TAC, FAC, AC-T and AC have 40% - 69% percentage incidence of mucositis; see http://t.co/HjHash6p for help. $ACCP

Fri, 03 Feb 2012 20:14:28 +0000

© 2012 ProActive Newsroom